Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Valproate is widely used in psychiatry and neurology, including off-label use. Here we consider its potential benefits and risks, particularly for women of childbearing potential, and the evidence that clinical guidelines are adhered to. Finally, we consider the implications for clinical practice and research into its efficacy in off-label indications.

Original publication

DOI

10.1192/bjp.2022.94

Type

Journal article

Journal

Br J Psychiatry

Publication Date

07/07/2022

Pages

1 - 3

Keywords

anticonvulsants, drug interactions and side-effects, education and training, polypharmacy, psychotic disorders